Author:
Einafshar Elham,Hashemi Maryam,Gholoobi Aida,Mobasheri Leila,Ghorbani Ahmad
Funder
National Institutes for Medical Research Development
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Bioengineering
Reference38 articles.
1. Sawosz, E., Jaworski, S., Kutwin, M., Vadalasetty, K. P., Grodzik, M., Wierzbicki, M., Kurantowicz, N., Strojny, B., Hotowy, A., & Lipińska, L. (2015). Graphene functionalized with arginine decreases the development of glioblastoma multiforme tumor in a gene-dependent manner. International journal of molecular sciences, 16(10), 25214–25233.
2. Walker, C., Baborie, A., Crooks, D., Wilkins, S., & Jenkinson, M. (2011). Biology, genetics and imaging of glial cell tumours. The British journal of radiology, 84(special_issue_2), 90–106.
3. Noch, E. K., Ramakrishna, R., & Magge, R. (2018). Challenges in the treatment of glioblastoma: Multisystem mechanisms of therapeutic resistance. World neurosurgery, 116, 505–517.
4. Lee, S. Y. (2016). Temozolomide resistance in glioblastoma multiforme. Genes & diseases, 3(3), 198–210.
5. Zhao, P.-H., Wei, Z., Wang, L.-H., Pang, C., Zhang, H.-R., Wang, J., & Wang, Y.-L. (2021). Delivery of temozolomide using PEGylated graphene oxide as a nanocarrier. Materials Express, 11(2), 189–195.